OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Genome Editing for Cystic Fibrosis
Guoshun Wang
Cells (2023) Vol. 12, Iss. 12, pp. 1555-1555
Open Access | Times Cited: 16
Guoshun Wang
Cells (2023) Vol. 12, Iss. 12, pp. 1555-1555
Open Access | Times Cited: 16
Showing 16 citing articles:
Update on advances in cystic fibrosis towards a cure and implications for primary care clinicians
Vito Terlizzi, Philip M. Farrell
Current problems in pediatric and adolescent health care (2024) Vol. 54, Iss. 6, pp. 101637-101637
Closed Access | Times Cited: 23
Vito Terlizzi, Philip M. Farrell
Current problems in pediatric and adolescent health care (2024) Vol. 54, Iss. 6, pp. 101637-101637
Closed Access | Times Cited: 23
CRISPR/Cas9 Landscape: Current State and Future Perspectives
Marina A. Tyumentseva, Marina A. Tyumentseva, В. Г. Акимкин
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 22, pp. 16077-16077
Open Access | Times Cited: 29
Marina A. Tyumentseva, Marina A. Tyumentseva, В. Г. Акимкин
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 22, pp. 16077-16077
Open Access | Times Cited: 29
Exploring Mechanisms of Lipid Nanoparticle‐Mucus Interactions in Healthy and Cystic Fibrosis Conditions
Belal Tafech, Mohammad‐Reza Rokhforouz, Jerry Leung, et al.
Advanced Healthcare Materials (2024) Vol. 13, Iss. 18
Open Access | Times Cited: 6
Belal Tafech, Mohammad‐Reza Rokhforouz, Jerry Leung, et al.
Advanced Healthcare Materials (2024) Vol. 13, Iss. 18
Open Access | Times Cited: 6
A new era of targeting cystic fibrosis with non-viral delivery of genomic medicines
Namratha Turuvekere Vittala Murthy, Kseniia Vlasova, Jonas Renner, et al.
Advanced Drug Delivery Reviews (2024) Vol. 209, pp. 115305-115305
Closed Access | Times Cited: 5
Namratha Turuvekere Vittala Murthy, Kseniia Vlasova, Jonas Renner, et al.
Advanced Drug Delivery Reviews (2024) Vol. 209, pp. 115305-115305
Closed Access | Times Cited: 5
Innovations and implementations of clustered regularly interspaced short palindromic repeats in next-generation diagnostic tools: A review of current and emerging techniques
Samudrala Lahari, Yogindran Sneha, Chitti Sathwika, et al.
Journal of Clinical Sciences (2025) Vol. 22, Iss. 1, pp. 36-41
Open Access
Samudrala Lahari, Yogindran Sneha, Chitti Sathwika, et al.
Journal of Clinical Sciences (2025) Vol. 22, Iss. 1, pp. 36-41
Open Access
RNA editing applied to cystic fibrosis: RESTORE can target G542X CFTR mRNA and revert the nonsense mutation
Simona Titoli, Viviana Barra, Silvia Gargano, et al.
Gene (2025), pp. 149384-149384
Open Access
Simona Titoli, Viviana Barra, Silvia Gargano, et al.
Gene (2025), pp. 149384-149384
Open Access
CRISPR/Cas9 gene editing for treating gene and protein disorders
Chukwuebuka Emmanuel Umeyor, Preeya Negi, R. Agarwal, et al.
Elsevier eBooks (2025), pp. 519-553
Closed Access
Chukwuebuka Emmanuel Umeyor, Preeya Negi, R. Agarwal, et al.
Elsevier eBooks (2025), pp. 519-553
Closed Access
Lymphoblastoid and Jurkat cell lines are useful surrogate in developing a CRISPR-Cas9 method to correct leukocyte adhesion deficiency genomic defect
A. Ramadan, Noureddine Ben Khalaf, Khaled Trabelsi, et al.
Frontiers in Bioengineering and Biotechnology (2025) Vol. 13
Open Access
A. Ramadan, Noureddine Ben Khalaf, Khaled Trabelsi, et al.
Frontiers in Bioengineering and Biotechnology (2025) Vol. 13
Open Access
Applications and Research Advances in the Delivery of CRISPR/Cas9 Systems for the Treatment of Inherited Diseases
Xinyue Lu, Miaomiao Zhang, Ge Li, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 17, pp. 13202-13202
Open Access | Times Cited: 12
Xinyue Lu, Miaomiao Zhang, Ge Li, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 17, pp. 13202-13202
Open Access | Times Cited: 12
Precision in Action: The Role of Clustered Regularly Interspaced Short Palindromic Repeats/Cas in Gene Therapies
Amrutha Banda, Olivia Impomeni, Aparana Singh, et al.
Vaccines (2024) Vol. 12, Iss. 6, pp. 636-636
Open Access | Times Cited: 3
Amrutha Banda, Olivia Impomeni, Aparana Singh, et al.
Vaccines (2024) Vol. 12, Iss. 6, pp. 636-636
Open Access | Times Cited: 3
CRISPR Advancements for Human Health.
Daniel J. Davis, Sai Goutham Reddy Yeddula
PubMed (2024) Vol. 121, Iss. 2, pp. 170-176
Closed Access | Times Cited: 2
Daniel J. Davis, Sai Goutham Reddy Yeddula
PubMed (2024) Vol. 121, Iss. 2, pp. 170-176
Closed Access | Times Cited: 2
Exploring Mechanisms of Lipid Nanoparticle-Mucus Interactions in Healthy and Cystic Fibrosis Conditions
Belal Tafech, Mohammad‐Reza Rokhforouz, Jerry Leung, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Belal Tafech, Mohammad‐Reza Rokhforouz, Jerry Leung, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Therapeutic Interventions for Pseudomonas Infections in Cystic Fibrosis Patients: A Review of Phase IV Trials
Mohammed Alqasmi
Journal of Clinical Medicine (2024) Vol. 13, Iss. 21, pp. 6530-6530
Open Access
Mohammed Alqasmi
Journal of Clinical Medicine (2024) Vol. 13, Iss. 21, pp. 6530-6530
Open Access
Advancing the Battle against Cystic Fibrosis: Stem Cell and Gene Therapy Insights
Disha D. Shah, Mehul R. Chorawala, Aanshi J. Pandya, et al.
Current Medical Science (2024)
Closed Access
Disha D. Shah, Mehul R. Chorawala, Aanshi J. Pandya, et al.
Current Medical Science (2024)
Closed Access
Nucleases: From Primitive Immune Defenders to Modern Biotechnology Tools
Frank J. Hernández
Immunology (2024)
Open Access
Frank J. Hernández
Immunology (2024)
Open Access
